Related content

Loperamide, an FDA-Approved Antidiarrhea Drug, Effectively Reverses the Resistance of Multidrug Resistant MCF-7/MDR1 Human Breast Cancer Cells to Doxorubicin-Induced Cytotoxicity

By Zhou Yanfei   Sridhar Rajagopalan   Shan Liang   Sha Wei   Gu Xinbin   Sukumar Saraswati  

Cancer Investigation, Vol. 30, Iss. 2, 2012-02 ,pp. : 119-125

Informa Healthcare

Access to resources Recommend Favorite

Molecular mechanisms of radiation resistance in doxorubicin-resistant breast adenocarcinoma cells

By          

International Journal of Oncology, Vol. 42, Iss. 5, 2013-01 ,pp. : 1692-1708

Spandidos Publications

Access to resources Recommend Favorite

Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin

By Kim KwangYoun   Kim SangHun   Yu SunNyoung   Park SuelKi   Choi HyeunDeok   Yu HakSun   Ji JaeHoon   Seo YoungKyo   Ahn SoonCheol  

Molecular Medicine Reports, Vol. 12, Iss. 2, 2015-08 ,pp. : 1898-1904

Spandidos Publications

Access to resources Recommend Favorite

Potent Killing of Paclitaxel- and Doxorubicin-resistant Breast Cancer Cells by Calphostin C Accompanied by Cytoplasmic Vacuolization

By Guo Baoqing   Hembruff Stacey L.   Villeneuve David J.   Kirwan Angie F.   Parissenti Amadeo M.  

Breast Cancer Research and Treatment, Vol. 82, Iss. 2, 2003-11 ,pp. : 125-141

Springer Publishing Company

Access to resources Recommend Favorite

A novel anthracene derivative, MHY412, induces apoptosis in doxorubicin-resistant MCF-7/Adr human breast cancer cells through cell cycle arrest and downregulation of P-glycoprotein expression

By                

International Journal of Oncology, Vol. 44, Iss. 1, 2014-01 ,pp. : 167-176

Spandidos Publications

Access to resources Recommend Favorite